“…In recent years, immunotherapy combined with nanotechnology, defined as nanoimmunotherapy, has shown promising performance for cancer therapy [ [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] ]. Among these therapeutics, metal-organic frameworks (MOFs), as a crystal material, has been widely studied in biomedical field [ [31] , [32] , [33] , [34] , [35] , [36] , [37] ]. MOFs of nanosized iron carboxylate, especially MIL101(Fe), have attracted considerable attention due to their excellent biocompatibility and biodegradability [ [38] , [39] , [40] ].…”